top of page
Avellino logo.png

CLIA validated, FDA EUA authorized Test performed in a high throughput, high complexity Testing Lab

Avellino Lab USA, Inc. Is a global leader in gene therapy and molecular diagnostics and is at the forefront of precision medicine for eye care. The company is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Beyond the Avellino CoV2 test, Avellino recently launched AvaGen, the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies and keratoconus genetic risk factors. Avellino is headquartered in Sillicon Valley, California, with operations in Korea, Japan, China, and the UK

Manufactured to the Highest Standards

Avellino kit pic.png
A non-invasive genetic test to identify the coronavirus

The Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2) is a non-invasive, swab based test used to detect the SARS-CoV-2 virus, a strong indicator of the patient having the COVID-19 disease. A positive result generally indicates an active infection, while a negative result should not be used as the sole basis for treatment or other patient management decisions. All results, whether positive or negative, must be combined with clinical observations, patient history, and epidemiological information for a proper medical diagnosis. AvellinoCoV2 was developed by Avellino Lab USA, Inc., in its CLIA-qualified lab and is authorized by the FDA under the Emergency Use Authorization.

Avenillo Guide1.png
Avenillo Guide2.png
Avenillo Guide3.png
Avenillo Guide5.png
Avenillo Guide4.png
Avellino Speed Matters.png
bottom of page